{"status": "OK", "response": {"docs": [{"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "The political debate over how to add a prescription drug benefit to Medicare has dragged on now for more than four years. Prescription drugs have become an integral part of health care delivery, but unlike insurance for most working families, the Medicare program for older and disabled people provides almost no drug coverage. Politicians from both parties know they have to do something, but the hurdles are big: money and control. The debate in the Senate is still ongoing. But large differences along party lines remain, and the Republican House plan that was passed on a party line vote in June makes hopes for compromise remote given the desires of consumers for broad coverage and of drug companies for minimal government controls.", "headline": {"main": "Finding a Formula for Medicare Drug Benefits"}, "abstract": "Marilyn Moon Op-Ed article examines obstacles thwarting Senate passage of bill to provide prescription drug benefits for Medicare recipients; says main problems are money and control, noting large differences between Republicans and Democrats and fact that sums needed are enormous; says lawmakers and rest of Americans must ultimately decide whether they trust government to deliver new drug benefit effectively; says need for drug coverage is too great to let issue remain unresolved (M)", "print_page": "19", "word_count": 786, "_id": "4fd28db88eb7c8105d863306", "snippet": "The political debate over how to add a prescription drug benefit to Medicare has dragged on now for more than four years. Prescription drugs have become an integral part of health care delivery, but unlike insurance for most working families, the...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/07/29/opinion/finding-a-formula-for-medicare-drug-benefits.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Marilyn", "lastname": "Moon"}], "original": "By Marilyn Moon"}, "document_type": "article", "pub_date": "2002-07-29T00:00:00Z", "section_name": "Health; Opinion"}], "meta": {"hits": 11, "offset": 10, "time": 177}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}